10-Q Filing

SRX HEALTH SOLUTIONS, INC. CIK: 1471727 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001185185-19-000530`
Period End Date	20190228
Filing Date	20190415
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	senz-20190228.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 59 Income Statement 82 Cash Flow Statement 82 Stockholders Equity 39

Balance Sheet 59 line items

Line Item	Tag	Value	Unit	Period
Convertible Notes, unamortized debt discounts (in Dollars)	`DebtInstrumentUnamortizedDiscount`	$752.99K	USD	Point-in-time
Convertible Notes, unamortized debt discounts (in Dollars)	`DebtInstrumentUnamortizedDiscount`	-	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares designated	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$253.43K	USD	Point-in-time
Preferred stock, shares designated	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.44K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$107.94K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$199.67K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$41.08K	USD	Point-in-time
Inventory	`InventoryNet`	$9.40K	USD	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$209.08K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$149.02K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	580.00M	shares	Point-in-time
Investment in TruPet	`Investments`	$2.20M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	580.00M	shares	Point-in-time
Investment in TruPet	`Investments`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	580.00M	shares	Point-in-time
Total Assets	`Assets`	$209.08K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.06M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	2.70M	shares	Point-in-time
Total Assets	`Assets`	$2.35M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	2.70M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.06M	shares	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$104.91K	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$106.44K	USD	Point-in-time
Accrued interest, related party	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Accrued interest, related party	`DueToRelatedPartiesCurrent`	$1.66K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$98.59K	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$20.28K	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$2.43M	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$2.32M	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$2.43M	USD	Point-in-time
Accrued officer salary	`DueToOfficersOrStockholdersCurrent`	$140.00K	USD	Point-in-time
Accrued officer salary	`DueToOfficersOrStockholdersCurrent`	$108.00K	USD	Point-in-time
Convertible notes, net of unamortized debt discounts of $0 and $752,990, respectively	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Convertible notes, net of unamortized debt discounts of $0 and $752,990, respectively	`ConvertibleNotesPayableCurrent`	$274.21K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.86M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.75M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value, 580,000,000 shares authorized 2,699,502 and 3,064,763 shares (post-reverse split) issued and outstanding as of February 28, 2019 and August 31, 2018, respectively	`CommonStockValue`	$2.70K	USD	Point-in-time
Common stock, $0.001 par value, 580,000,000 shares authorized 2,699,502 and 3,064,763 shares (post-reverse split) issued and outstanding as of February 28, 2019 and August 31, 2018, respectively	`CommonStockValue`	$3.06K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$3.41M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.32M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-6.06M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.72M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-190.51K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-396.61K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-2.65M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-1.22M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-1.18M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-1.68M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$2.35M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$209.08K	USD	Point-in-time

Income Statement 82 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$475.00	USD	2 Qtrs
Revenue	`Revenues`	-	USD	2 Qtrs
Revenue	`Revenues`	$261.00	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Cost of goods sold	`CostOfGoodsAndServicesSold`	$184.00	USD	1 Quarter
Cost of goods sold	`CostOfGoodsAndServicesSold`	$211.00	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsAndServicesSold`	-	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsAndServicesSold`	-	USD	1 Quarter
Gross profit	`GrossProfit`	-	USD	2 Qtrs
Gross profit	`GrossProfit`	$264.00	USD	2 Qtrs
Gross profit	`GrossProfit`	-	USD	1 Quarter
Gross profit	`GrossProfit`	$77.00	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$536.43K	USD	2 Qtrs
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$388.90K	USD	1 Quarter
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$151.72K	USD	2 Qtrs
Selling, general and administrative	`GeneralAndAdministrativeExpense`	$66.48K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$388.90K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$66.48K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$151.72K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$536.43K	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-536.43K	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-66.40K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-151.46K	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-388.90K	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-768.13K	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-368.00	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-133.91K	USD	2 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-449.14K	USD	2 Qtrs
Excess value of warrants liability over net proceeds of sale of common stock at inception	`OtherExpenses`	$3.68M	USD	1 Quarter
Excess value of warrants liability over net proceeds of sale of common stock at inception	`OtherExpenses`	$3.68M	USD	2 Qtrs
Excess value of warrants liability over net proceeds of sale of common stock at inception	`OtherExpenses`	-	USD	2 Qtrs
Gain on exchange of debt and equity	`GainsLossesOnRestructuringOfDebt`	$472.27K	USD	2 Qtrs
Gain on exchange of debt and equity	`GainsLossesOnRestructuringOfDebt`	$139.32K	USD	2 Qtrs
Gain on exchange of debt and equity	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Gain on exchange of debt and equity	`GainsLossesOnRestructuringOfDebt`	$139.32K	USD	1 Quarter
Gain (loss) on change in fair value of derivative liability	`GainLossOnDerivativeInstrumentsNetPretax`	$-600.92K	USD	2 Qtrs
Gain (loss) on change in fair value of derivative liability	`GainLossOnDerivativeInstrumentsNetPretax`	$4.21M	USD	2 Qtrs
Gain (loss) on change in fair value of derivative liability	`GainLossOnDerivativeInstrumentsNetPretax`	$-256.29K	USD	1 Quarter
Gain (loss) on change in fair value of derivative liability	`GainLossOnDerivativeInstrumentsNetPretax`	$3.90M	USD	1 Quarter
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$875.59K	USD	2 Qtrs
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$-885.09K	USD	1 Quarter
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$-910.74K	USD	2 Qtrs
Total other income (expense), net	`OtherNonoperatingIncomeExpense`	$222.85K	USD	1 Quarter
Net (loss) income before tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-951.49K	USD	1 Quarter
Net (loss) income before tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.06M	USD	2 Qtrs
Net (loss) income before tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$339.16K	USD	2 Qtrs
Net (loss) income before tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-166.06K	USD	1 Quarter
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$-110.70K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-1.06M	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$-166.06K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-951.49K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$339.16K	USD	2 Qtrs
Net (loss) income	`NetIncomeLoss`	$502.22K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$109.93K	USD	2 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	-	USD	2 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	-	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$41.15K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$68.79K	USD	1 Quarter
Net (loss) income available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$229.23K	USD	2 Qtrs
Net (loss) income available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-234.85K	USD	1 Quarter
Net (loss) income available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.06M	USD	2 Qtrs
Net (loss) income available to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-951.49K	USD	1 Quarter
Net loss (income) per share basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.31	USD	1 Quarter
Net loss (income) per share basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.35	USD	2 Qtrs
Net loss (income) per share basic (in Dollars per share)	`EarningsPerShareBasic`	$0.08	USD	2 Qtrs
Net loss (income) per share basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Net loss (income) per share - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.35	USD	2 Qtrs
Net loss (income) per share - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Net loss (income) per share - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$0.06	USD	2 Qtrs
Net loss (income) per share - diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.31	USD	1 Quarter
Weighted average shares outstanding - basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	3.03M	shares	2 Qtrs
Weighted average shares outstanding - basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	2.72M	shares	1 Quarter
Weighted average shares outstanding - basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	2.88M	shares	2 Qtrs
Weighted average shares outstanding - basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	3.04M	shares	1 Quarter
Weighted average shares outstanding diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	3.04M	shares	1 Quarter
Weighted average shares outstanding diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	3.03M	shares	2 Qtrs
Weighted average shares outstanding diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	2.72M	shares	1 Quarter
Weighted average shares outstanding diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	5.45M	shares	2 Qtrs

Cash Flow Statement 82 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`IncomeLossFromContinuingOperations`	$-1.06M	USD	2 Qtrs
Net income (loss)	`IncomeLossFromContinuingOperations`	$339.16K	USD	2 Qtrs
Gain on exchange transaction	`GainsLossesOnRestructuringOfDebt`	$472.27K	USD	2 Qtrs
Gain on exchange transaction	`GainsLossesOnRestructuringOfDebt`	$139.32K	USD	2 Qtrs
Gain on exchange transaction	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Gain on exchange transaction	`GainsLossesOnRestructuringOfDebt`	$139.32K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$4.21M	USD	2 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-600.92K	USD	2 Qtrs
Amortization of discount on convertible debt	`AmortizationOfDebtDiscountPremium`	$397.81K	USD	2 Qtrs
Amortization of discount on convertible debt	`AmortizationOfDebtDiscountPremium`	$118.71K	USD	2 Qtrs
Fair value of vested stock options	`ShareBasedCompensation`	$51.66K	USD	2 Qtrs
Fair value of vested stock options	`ShareBasedCompensation`	-	USD	2 Qtrs
Excess value of warrants liability over net proceeds of sale of common stock at inception	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$3.68M	USD	2 Qtrs
Excess value of warrants liability over net proceeds of sale of common stock at inception	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	2 Qtrs
Gain on note exchange	`GainsLossesOnRestructuringOfDebt`	$472.27K	USD	2 Qtrs
Gain on note exchange	`GainsLossesOnRestructuringOfDebt`	$139.32K	USD	2 Qtrs
Gain on note exchange	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Gain on note exchange	`GainsLossesOnRestructuringOfDebt`	$139.32K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$41.08K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-211.00	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-9.40K	USD	2 Qtrs
Accrued officer salary	`IncreaseDecreaseInAccruedLiabilities`	$-32.00K	USD	2 Qtrs
Accrued officer salary	`IncreaseDecreaseInAccruedLiabilities`	$40.00K	USD	2 Qtrs
Interest payable - related party	`IncreaseDecreaseInInterestPayableNet`	$1.66K	USD	2 Qtrs
Interest payable - related party	`IncreaseDecreaseInInterestPayableNet`	$1.01K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-4.45K	USD	2 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$64.76K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-166.01K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-497.23K	USD	2 Qtrs
Deposit made on investment in TruPet	`PaymentsToAcquireEquityMethodInvestments`	-	USD	2 Qtrs
Deposit made on investment in TruPet	`PaymentsToAcquireEquityMethodInvestments`	$2.20M	USD	Point-in-time
Deposit made on investment in TruPet	`PaymentsToAcquireEquityMethodInvestments`	$2.20M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.20M	USD	2 Qtrs
Cash paid for the purchase of common stock	`ProceedsFromIssuanceOfCommonStock`	$-51.60K	USD	2 Qtrs
Cash paid for the purchase of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Cash from sale of common stock, net of costs	`ProceedsFromIssuanceOrSaleOfEquity`	$2.78M	USD	Point-in-time
Cash from sale of common stock, net of costs	`ProceedsFromIssuanceOrSaleOfEquity`	$2.66M	USD	2 Qtrs
Cash from sale of common stock, net of costs	`ProceedsFromIssuanceOrSaleOfEquity`	$2.66M	USD	1 Quarter
Cash from sale of common stock, net of costs	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	2 Qtrs
Proceeds from notes payable - related party	`ProceedsFromRelatedPartyDebt`	$35.50K	USD	2 Qtrs
Proceeds from notes payable - related party	`ProceedsFromRelatedPartyDebt`	-	USD	2 Qtrs
Repayments of notes payable - related party	`RepaymentsOfRelatedPartyDebt`	-	USD	2 Qtrs
Repayments of notes payable - related party	`RepaymentsOfRelatedPartyDebt`	$100.00K	USD	2 Qtrs
Proceeds from convertible debt	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$482.50K	USD	2 Qtrs
Proceeds from convertible debt	`ProceedsFromRepaymentsOfRelatedPartyDebt`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.61M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$418.00K	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-91.74K	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$251.99K	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$253.43K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.44K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$107.94K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$199.67K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$253.43K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.44K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$107.94K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$199.67K	USD	Point-in-time
Interest paid	`InterestPaidNet`	-	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$1.09K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	-	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	-	USD	2 Qtrs
Common stock issued for conversion of notes payable and accrued interest	`DebtConversionConvertedInstrumentAmount1`	-	USD	2 Qtrs
Common stock issued for conversion of notes payable and accrued interest	`DebtConversionConvertedInstrumentAmount1`	$84.96K	USD	2 Qtrs
Preferred Stock Series E issued for cancellation of convertible notes payable, accrued interest, Series B Preferred Stock and warrants	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	2 Qtrs
Preferred Stock Series E issued for cancellation of convertible notes payable, accrued interest, Series B Preferred Stock and warrants	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$2.02M	USD	2 Qtrs
Discount on notes payable due to beneficial conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	2 Qtrs
Discount on notes payable due to beneficial conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$891.17K	USD	2 Qtrs
Settlement of derivative	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	$476.94K	USD	2 Qtrs
Settlement of derivative	`OtherSignificantNoncashTransactionValueOfConsiderationReceived1`	$2.00M	USD	2 Qtrs
Accrued interest capitalized into principal of convertible notes payable	`InterestCostsCapitalized`	-	USD	2 Qtrs
Accrued interest capitalized into principal of convertible notes payable	`InterestCostsCapitalized`	$15.82K	USD	2 Qtrs
Fair value of warrants issued with sale of common stock allocated to additional paid in capital	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$333.95K	USD	1 Quarter
Fair value of warrants issued with sale of common stock allocated to additional paid in capital	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$2.00M	USD	Point-in-time
Fair value of warrants issued with sale of common stock allocated to additional paid in capital	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	-	USD	2 Qtrs
Fair value of warrants issued with sale of common stock allocated to additional paid in capital	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$2.66M	USD	2 Qtrs
Accrued preferred stock dividends	`DividendsPreferredStock`	$109.93K	USD	2 Qtrs
Accrued preferred stock dividends	`DividendsPreferredStock`	-	USD	2 Qtrs
Accrued preferred stock dividends	`DividendsPreferredStock`	-	USD	1 Quarter
Accrued preferred stock dividends	`DividendsPreferredStock`	$41.15K	USD	1 Quarter
Accrued preferred stock dividends	`DividendsPreferredStock`	$68.79K	USD	1 Quarter

Stockholders Equity 39 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-190.51K	USD	Point-in-time
Balance	`StockholdersEquity`	$-396.61K	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.22M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.18M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.68M	USD	Point-in-time
Options vested	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$51.66K	USD	1 Quarter
Exchange agreement	`StockIssuedDuringPeriodValueOther`	$2.02M	USD	1 Quarter
Purchase and retirement of common stock	`StockRepurchasedAndRetiredDuringPeriodValue`	$-27.27K	USD	1 Quarter
Purchase and retirement of common stock	`StockRepurchasedAndRetiredDuringPeriodValue`	$-24.33K	USD	1 Quarter
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$2.02M	USD	Point-in-time
Sale of common stock	`StockIssuedDuringPeriodValueNewIssues`	$2.66M	USD	1 Quarter
Sale of common stock (in Shares)	`StockIssuedDuringPeriodSharesNewIssues`	1.43M	shares	1 Quarter
Conversion of Preferred Series (in Shares)	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	62,856.00	shares	Point-in-time
Conversion of Preferred Series (in Shares)	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	115.00	shares	Point-in-time
Excess value of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$2.66M	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$109.93K	USD	2 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	-	USD	2 Qtrs
Preferred stock dividend	`DividendsPreferredStock`	-	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$41.15K	USD	1 Quarter
Preferred stock dividend	`DividendsPreferredStock`	$68.79K	USD	1 Quarter
Conversion of notes payable and accrued interest	`StockholdersEquityOther`	$78.45K	USD	1 Quarter
Conversion of notes payable and accrued interest	`StockholdersEquityOther`	$149.50K	USD	1 Quarter
Settlement of derivative liabilities	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$333.95K	USD	1 Quarter
Settlement of derivative liabilities	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$2.00M	USD	Point-in-time
Settlement of derivative liabilities	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	-	USD	2 Qtrs
Settlement of derivative liabilities	`EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity`	$2.66M	USD	2 Qtrs
Net income (loss) for the period	`NetIncomeLoss`	$-110.70K	USD	1 Quarter
Net income (loss) for the period	`NetIncomeLoss`	$-1.06M	USD	2 Qtrs
Net income (loss) for the period	`NetIncomeLoss`	$-166.06K	USD	1 Quarter
Net income (loss) for the period	`NetIncomeLoss`	$-951.49K	USD	1 Quarter
Net income (loss) for the period	`NetIncomeLoss`	$339.16K	USD	2 Qtrs
Net income (loss) for the period	`NetIncomeLoss`	$502.22K	USD	1 Quarter
Balance	`StockholdersEquity`	$-190.51K	USD	Point-in-time
Balance	`StockholdersEquity`	$-396.61K	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.22M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.18M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.68M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.